Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study (Q30548231)

19 August 2017

1 reference

Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study (English)

1 reference

19 August 2017

Steven E Kahn

6

0 references

Bertram Pitt

10

object named as

Bertram Pitt

1 reference

19 August 2017

8

Cora E Lewis

1 reference

19 August 2017

11

Monika M Safford

1 reference

19 August 2017

5

Steven Haffner

1 reference

19 August 2017

3

Curt D Furberg

1 reference

19 August 2017

Frederick L Brancati

1

1 reference

19 August 2017

Mary Evans

2

1 reference

19 August 2017

Nancy Geller

4

1 reference

19 August 2017

Peter G Kaufmann

7

1 reference

19 August 2017

David M Nathan

9

1 reference

19 August 2017

Look AHEAD Study Group

12

1 reference

19 August 2017

1 February 2012

1 reference

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

1

1 reference

19 August 2017

113-124

1 reference

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Body-Mass Index and Mortality among 1.46 Million White Adults

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Paired comparison of observed and expected coronary heart disease rates over 12 years from the Atherosclerosis Risk in Communities Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Comparison of registered and published primary outcomes in randomized controlled trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Composite outcomes in cardiovascular research: a survey of randomized trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

When and how can endpoints be changed after initiation of a randomized clinical trial?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

On changing a long-term clinical trial midstream

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3790961

Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes

20 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511432726

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22334468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22334468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/1740774511432726

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

22334468

1 reference